On Friday, Kyverna Therapeutics Inc (NASDAQ: KYTX) opened lower -6.70% from the last session, before settling in for the closing price of $9.4. Price fluctuations for KYTX have ranged from $1.78 to $13.67 over the past 52 weeks.
Company’s average yearly earnings per share was noted -12.52% at the time writing. With a float of $28.40 million, this company’s outstanding shares have now reached $43.79 million.
Kyverna Therapeutics Inc (KYTX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Kyverna Therapeutics Inc is 50.28%, while institutional ownership is 24.36%. The most recent insider transaction that took place on Dec 18 ’25, was worth 999,998. In this transaction Director of this company bought 133,333 shares at a rate of $7.50, taking the stock ownership to the 869,317 shares. Before that another transaction happened on Dec 18 ’25, when Company’s 10% Owner bought 133,333 for $7.50, making the entire transaction worth $999,998. This insider now owns 869,317 shares in total.
Kyverna Therapeutics Inc (KYTX) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.88 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.82) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.52% per share during the next fiscal year.
Kyverna Therapeutics Inc (NASDAQ: KYTX) Trading Performance Indicators
Check out the current performance indicators for Kyverna Therapeutics Inc (KYTX). In the past quarter, the stock posted a quick ratio of 5.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.72, a number that is poised to hit -0.89 in the next quarter and is forecasted to reach -3.63 in one year’s time.
Technical Analysis of Kyverna Therapeutics Inc (KYTX)
As of the previous 9 days, the stock’s Stochastic %D was 80.94%.
During the past 100 days, Kyverna Therapeutics Inc’s (KYTX) raw stochastic average was set at 54.92%, which indicates a significant increase from 30.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.98 in the past 14 days, which was higher than the 0.62 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.70, while its 200-day Moving Average is $4.57. Now, the first resistance to watch is $9.38. This is followed by the second major resistance level at $9.99. The third major resistance level sits at $10.43. If the price goes on to break the first support level at $8.33, it is likely to go to the next support level at $7.89. The third support level lies at $7.28 if the price breaches the second support level.
Kyverna Therapeutics Inc (NASDAQ: KYTX) Key Stats
There are currently 43,796K shares outstanding in the company with a market cap of 501.03 million. Presently, the company’s annual sales total 0 K according to its annual income of -127,480 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -36,790 K.
